ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition (NASDAQ:CLPT)

Earnings Call InsightsClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisitionMar. 17, 2026 7:42 PM ETClearPoint Neuro, Inc. (CLPT) StockAI-Generated Earnings Calls InsightsCommentsEarnings Call Insights: ClearPoint Neuro (CLPT) Q4 2025 Management View CEO Joseph Burnett stated that ClearPoint Neuro ended 2025 on its strongest financial quarter of the year, highlighting "a newly acquired and commercialized neurocritical care product line an ...